PAYAL KADAKIA: Open Payments
NPI 1336819556 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$62 in 3 payments from 2 companies in 2025. Trend: 2023 $3,468 · 2024 $417 · 2025 $62
Food & beverage: $62
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
Products named: SAPIEN 3 Ultra RESILIA, AMVUTTRA.
Industry payments across DC — which companies pay providers there.
